AMS provides procedures and medical devices for pelvic health. The combined company will offer healthcare solutions for urology and pain.
On a 2011 pro forma basis, the combined company would have had revenues of approximately $3 billion. By 2013, Endo expects to gain $50 million in cost synergies from duplicative SG&A expenditures, manufacturing efficiencies and procurement savings.
The transaction has been unanimously approved by the boards of directors of both companies and must now be approved by AMS stockholders and antitrust authorities. The acquisition is expected to close late in the third quarter of 2011.
Read the Endo release on its acquisition of American Medical Systems.
Read more supply chain coverage:
– Nonprofit Foundation Offers Financial Assistance for Children’s Medical Needs
– Electronic Health Records: What Does it Mean and Do We Have to Go There?
– Healthcare, Recycling and Waste Management Companies Form Healthcare Plastics Recycling Council
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
